Intended for healthcare professionals

Rapid response to:

Head To Head

Should we rename low risk cancers?

BMJ 2019; 364 doi: (Published 23 January 2019) Cite this as: BMJ 2019;364:k4699

Rapid Response:

Re: Should we rename low risk cancers?

The most striking thing about this debate: the “yes” argument is written by a cancer surgeon, and “no” is by... a pathologist.

It is easy to tell who has more contact with patients.

Competing interests: No competing interests

26 January 2019
David Spitzer
PHGH Doctors
23 Temple Fortune Lane, London NW11